Effects of amantadine withdrawal after long-term use in Parkinson's disease

被引：0
|
作者：
Akhtar, F.
Rajput, M. L.
Rajput, A.
Rajput, A. H.
机构：
来源：
MOVEMENT DISORDERS | 2011年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
825
引用
收藏
页码：S277 / S278
页数：2
相关论文
共 50 条
  • [21] Long-term Safety and Clinical Effects of Nilotinib in Parkinson's Disease
    Pagan, Fernando
    Torres-Yaghi, Yasar
    Hebron, Michaeline
    Ahn, Jaeil
    Moussa, Charbel
    NEUROLOGY, 2021, 96 (15)
  • [22] An evaluation of persisting cognitive effects after withdrawal from long-term benzodiazepine use
    Barker, MJ
    Greenwood, KM
    Jackson, M
    Crowe, SF
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2005, 11 (03) : 281 - 289
  • [23] Long-term effects of amantadine in parkinsonian (AMANDYSK)
    Ory-Magne, F.
    Thalamas, C.
    Galitsky, M.
    Salis, A.
    Sommet, A.
    Pourcel, L.
    Azulay, J. P.
    Damier, P.
    Destee, A.
    Durif, F.
    Lacomblez, L.
    Tison, F.
    Viallet, F.
    Rascol, O.
    MOVEMENT DISORDERS, 2012, 27 : S132 - S132
  • [24] WITHDRAWAL REACTION AFTER LONG-TERM THERAPEUTIC USE OF BENZODIAZEPINES
    BUSTO, U
    SELLERS, EM
    NARANJO, CA
    CAPPELL, H
    SANCHEZCRAIG, M
    SYKORA, K
    NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (14): : 854 - 859
  • [25] Long-Term Outcome After Infliximab Withdrawal for Sustained Remission in Crohn's Disease
    Reenaers, Catherine
    Mary, Jean-Yves
    Nachury, Maria
    Bouhnik, Yoram
    Laharie, David
    Allez, Matthieu
    Dupas, Jean-Louis
    Amiot, Aurelien
    Savoye, Guillaume
    Altwegg, Romain
    De Vos, Martine
    Malamut, Georgia
    Boureille, Arnaud
    Flourie, Bernard
    Marteau, Philippe R.
    Vuitton, Lucine
    Coffin, Benoit
    Viennot, Stephanie
    Colombel, Jean-Frederic
    Louis, Edouard
    GASTROENTEROLOGY, 2016, 150 (04) : S72 - S72
  • [26] Long term use of apomorphine in Parkinson's disease
    Tagaris, G.
    Sakkou, V.
    Alexoudi, A.
    Logiotatos, N.
    Karageorgiou, C.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S112 - S112
  • [27] EFFECTS OF WITHDRAWAL FROM LONG-TERM NICOTINE GUM USE
    WEST, RJ
    RUSSELL, MAH
    PSYCHOLOGICAL MEDICINE, 1985, 15 (04) : 891 - 893
  • [28] Long-term effects of rasagiline and the natural history of treated Parkinson's disease
    Rascol, Olivier
    Hauser, Robert A.
    Stocchi, Fabrizio
    Fitzer-Attas, Cheryl J.
    Sidi, Yulia
    Abler, Victor
    Olanow, C. Warren
    MOVEMENT DISORDERS, 2016, 31 (10) : 1489 - 1496
  • [29] Long-term mildronate neuroprotective effects in a rat model of Parkinson's disease
    Isajevs, S.
    Svirina, D.
    Pupure, J.
    Rumaks, J.
    Svirskis, S.
    Dzirkale, Z.
    Jansone, B.
    Klusa, V. Z.
    VIRCHOWS ARCHIV, 2011, 459 : S270 - S270
  • [30] Long-term non-motor effects of Opicapone in Parkinson's disease
    Leta, V.
    Van Wamelen, D.
    Aureli, F.
    Trivedi, D.
    Batzu, L.
    Rizos, A.
    Cortelli, P.
    Chaudhuri, K. Ray
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 613 - 614
12345